Tag Archives: Pharma

Pelosi lieutenant to payers: Help us defeat Big Pharma

House Speaker Nancy Pelosi’s senior adviser on healthcare pitched the California representative’s drug plan to a ballroom full of insurance industry players Monday and called on them to support the bill aiming to take on the pharmaceutical industry.  While AHIP already praised the effort as a bold approach, Wendell Primus tried to convince the crowd that… Read More »

GSK poaches Merck KGaA exec to replace departing U.S. pharma president Bailey

GlaxoSmithKline has seen plenty of changes across its executive ranks over the last couple of years as CEO Emma Walmsley took the helm, but they’re still coming. Monday, the company said Jack Bailey, its U.S. pharma president and a veteran at the drugmaker, would step down at the end of the year. He’ll be succeeded… Read More »

Novartis bids goodbye to Hudson, hello to new pharma chief Tschudin

In the game of executive musical chairs triggered by Sanofi CEO Olivier Brandicourt’s exit, Novartis lost its pharma chief, Paul Hudson. But it was ready with a replacement: Marie-France Tschudin, who joined the company in January 2017 from Celgene. Tschudin takes the baton from Hudson as Novartis revs up several new launches and builds out… Read More »

Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns

Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More »

Shoppers takes page from Big Pharma, sponsors talks for doctors on medical cannabis, which it plans to sell

The pharmaceutical industry has done it for years, officially to educate doctors, unofficially to convince them to prescribe more of their medicines. Now the practice of company-sponsored seminars by specialists known in the drug business as “key opinion leaders” — and criticized as salespeople in disguise – has come to the burgeoning world of medical… Read More »

Why Pharma Risk Is Inherently Unpredictable And Why It Matters

In the grip of an innovation crisis, pharma struggles to deliver miracle medicines despite declining productivity. (Getty Royalty Free) Why does it matter if drug development is inherently unpredictable and not simply high risk? The question strikes many in an industry with an end-to-end success rate of between 2% and 3% as (a) obvious and… Read More »